mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.0071 |
0.8 |